Sort   by:  
 Page size 
UnknownNivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569692 | biostudies-literature
UnknownNivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569693 | biostudies-literature
UnknownColistin Resistance Gene mcr-1 in Avian-Pathogenic Escherichia coli in South Africa.
Not available
S-EPMC4914693 | biostudies-literature
UnknownLong-Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice.
Not available
S-EPMC8328801 | biostudies-literature
UnknownHealth-related material needs and substance use among emergency department patients.
Not available
S-EPMC6994322 | biostudies-literature
UnknownLive Imaging of Influenza Infection of the Trachea Reveals Dynamic Regulation of CD8+ T Cell Motility by Antigen.
Not available
S-EPMC5028057 | biostudies-literature
UnknownDegradation in carbon stocks near tropical forest edges.
Not available
S-EPMC4703854 | biostudies-literature
UnknownHealth-Related Social Needs Among Emergency Department Patients with HIV.
Not available
S-EPMC9185664 | biostudies-literature
UnknownHysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.
Not available
S-EPMC5881615 | biostudies-literature
TranscriptomicsTranscription profiling by array of Arabidopsis thaliana stems to investigate the transcriptome of myb103 mutants to better understand the mechanism underlying MYB103 action
Two null mutants of MYB103 were found to have decreased expression of FERULATE-5-HYDROXYLASE and reduced syringyl lignin in the basal inflorescence stem. The aim with this microarray experiment was to investigate the transcriptome of these myb103 mutants to better understand the mechanism underlying...
ORGANISM(S): Arabidopsis thaliana 
2012-09-01 | E-MEXP-3680 | biostudies-arrayexpress
Sort   by:  
 Page size